文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

印度注射毒品的年轻人 HIV 发病率和行为风险较高:一项横断面研究。

Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.

机构信息

Division of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

J Int AIDS Soc. 2019 May;22(5):e25287. doi: 10.1002/jia2.25287.


DOI:10.1002/jia2.25287
PMID:31116005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6530044/
Abstract

INTRODUCTION: There are limited data on young people who inject drugs (PWID) from low- and middle-income countries where injection drug use remains a key driver of new HIV infections. India has a diverse injection drug use epidemic and estimates suggest that at least half of PWID are ≤30 years of age. We compared injection and sexual risk behaviours and HIV incidence between younger and older PWID and characterized uptake of HIV testing and harm reduction services to inform targeted HIV prevention efforts. METHODS: We analysed cross-sectional data from 14,381 PWID recruited from cities in the Northeast and North/Central regions of India in 2013 using respondent driven sampling (RDS). We compared "emerging-adult" (18 to 24 years, 26% of sample) and "young-adult" PWID (25 to 30 years, 30% of sample) to older PWID (>30 years, 44% of sample) using logistic regression to evaluate factors associated with three recent risk behaviours: needle-sharing, multiple sexual partners and unprotected sex. We estimated age-stratified cross-sectional HIV incidence using a validated multi-assay algorithm. RESULTS: Compared to older adults, emerging-adults in the Northeastern states were significantly more likely to share needles (males adjusted odds ratio [aOR] 1.82; females aOR 2.29, p < 0.01), have multiple sexual partners (males aOR 1.56; females aOR 3.75, p < 0.01), and engage in unprotected sex (males aOR 2.29, p < 0.01). In the North/Central states, young-adult males were significantly more likely to needle-share (aOR 1.23, p < 0.05) while emerging-adult males were significantly more likely to have multiple sexual partners (aOR 1.74, p < 0.05). In both regions, emerging-adults had the lowest HIV testing. Participation in harm reduction services was low across all age groups. Annual HIV incidence was higher in emerging- and young-adult PWID in the North/Central region: emerging-adults: 4.3% (95% confidence interval [CI] 3.0, 5.6); young-adults: 4.9% (95% CI 3.7, 6.2); older adults: 2.1% (95% CI 1.4, 2.8). CONCLUSIONS: Higher HIV incidence and engagement in risky behaviours among younger PWID compared to older PWID, coupled with low utilization of harm reduction services highlight the importance of targeting this population in HIV programming. Age-specific interventions focused on addressing the needs of young PWID are urgently needed to curb the HIV epidemic in this vulnerable population.

摘要

介绍:在注射毒品的年轻人(PWID)中,来自中低收入国家的数据有限,而这些国家的注射毒品使用仍然是新的 HIV 感染的主要驱动因素。印度的注射毒品使用流行情况多种多样,据估计,至少有一半的 PWID 年龄在 30 岁以下。我们比较了年轻和年长的 PWID 的注射和性风险行为以及 HIV 发病率,并描述了 HIV 检测和减少伤害服务的采用情况,以为有针对性的 HIV 预防工作提供信息。

方法:我们使用回应驱动抽样(RDS)分析了 2013 年从印度东北部和北部/中部城市招募的 14381 名 PWID 的横断面数据。我们使用逻辑回归比较了“新兴成人”(18 至 24 岁,样本的 26%)和“青年成人”(25 至 30 岁,样本的 30%)与年长的 PWID(>30 岁,样本的 44%),以评估与最近三种风险行为相关的因素:共用针头、多个性伴侣和无保护性行为。我们使用经过验证的多分析物算法估计了年龄分层的横断面 HIV 发病率。

结果:与年长的成年人相比,东北地区的新兴成人更有可能共用针头(男性调整后的优势比 [aOR] 1.82;女性 aOR 2.29,p<0.01)、有多个性伴侣(男性 aOR 1.56;女性 aOR 3.75,p<0.01)和发生无保护性行为(男性 aOR 2.29,p<0.01)。在北部/中部各州,年轻男性更有可能共用针头(aOR 1.23,p<0.05),而新兴男性更有可能有多个性伴侣(aOR 1.74,p<0.05)。在两个地区,新兴成人的 HIV 检测率最低。所有年龄组的减少伤害服务参与率都很低。在北部/中部地区,新兴成人和青年成人的 HIV 发病率均较高:新兴成人:4.3%(95%置信区间 [CI] 3.0,5.6);青年成人:4.9%(95% CI 3.7,6.2);年长成人:2.1%(95% CI 1.4,2.8)。

结论:与年长的 PWID 相比,年轻的 PWID 具有更高的 HIV 发病率和风险行为,再加上减少伤害服务的利用率较低,这突出表明在 HIV 规划中针对这一人群的重要性。迫切需要针对年轻 PWID 的特定年龄干预措施,以遏制这一脆弱人群中的 HIV 流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc1/6530044/91314c4bc160/JIA2-22-e25287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc1/6530044/91314c4bc160/JIA2-22-e25287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc1/6530044/91314c4bc160/JIA2-22-e25287-g001.jpg

相似文献

[1]
Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.

J Int AIDS Soc. 2019-5

[2]
Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.

Addiction. 2017-8

[3]
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).

BMC Public Health. 2016-9-5

[4]
Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.

Harm Reduct J. 2024-10-18

[5]
Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.

Harm Reduct J. 2018-5-18

[6]
Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.

Afr J AIDS Res. 2018-9

[7]
Injecting drug use in Manipur and Nagaland, Northeast India: injecting and sexual risk behaviours across age groups.

Harm Reduct J. 2014-10-13

[8]
Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India.

PLoS One. 2017-1-18

[9]
Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.

Harm Reduct J. 2019-4-11

[10]
Unsafe injecting practices, sexual risk behaviours and determinants of HIV among men who inject drugs: Results from Integrated Biological and Behavioural Surveillance in India.

Int J STD AIDS. 2018-11

引用本文的文献

[1]
Seroprevalence of HIV, HCV, and HBV: The Associated Psychiatric Co-morbidities Among Injection Drug Users in Kashmir- A Hospital-Based Cross-sectional Study.

Indian J Psychol Med. 2024-6-16

[2]
Expanding single-venue services to better engage young people who inject drugs: insights from India.

Harm Reduct J. 2024-9-14

[3]
Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco.

Int J Drug Policy. 2024-9

[4]
Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.

J Int AIDS Soc. 2024-4

[5]
Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.

Addiction. 2024-3

[6]
HIV and its associated factors among people who inject drugs in Mizoram, Northeast India.

PLoS One. 2023

[7]
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.

Lancet Gastroenterol Hepatol. 2023-6

[8]
Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?

Front Public Health. 2022

[9]
Young and invisible: a qualitative study of service engagement by people who inject drugs in India.

BMJ Open. 2021-9-21

[10]
Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.

PLoS One. 2021-2-25

本文引用的文献

[1]
Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention.

Curr HIV/AIDS Rep. 2018-8

[2]
Effect of population viral load on prospective HIV incidence in a hyperendemic rural African community.

Sci Transl Med. 2017-12-13

[3]
Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.

PLoS Med. 2017-11-28

[4]
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.

Lancet Glob Health. 2017-10-23

[5]
Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.

J Infect Dis. 2017-11-27

[6]
Injection Drug Network Characteristics Are Important Markers of HIV Risk Behavior and Lack of Viral Suppression.

J Acquir Immune Defic Syndr. 2017-7-1

[7]
Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India.

BMC Health Serv Res. 2016-11-14

[8]
HIV decline associated with changes in risk behaviours among young key populations in Nepal: analysis of population-based HIV prevalence surveys between 2001 and 2012.

Int J STD AIDS. 2017-8

[9]
Our future: a Lancet commission on adolescent health and wellbeing.

Lancet. 2016-6-11

[10]
Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Lancet HIV. 2016-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索